Metabolic Burden Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Is a Prognostic Factor in Patients with Small Cell Lung Cancer
Mi-Hyun Kim, Ji Seok Lee, Jeong Ha Mok, Kwangha Lee, Ki Uk Kim, Hye-Kyung Park, Seong-Jang Kim, Min Ki Lee
Cancer Res Treat. 2014;46(2):165-171.   Published online 2014 Apr 15     DOI: https://doi.org/10.4143/crt.2014.46.2.165
Citations to this article as recorded by Crossref logo
Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET–CT metabolic parameters in small cell lung cancer (SCLC)
Cem Mirili, Isa Burak Guney, Semra Paydas, Gulsah Seydaoglu, Tuba Korkmaz Kapukaya, Ali Ogul, Serkan Gokcay, Mahmut Buyuksimsek, Abdullah Evren Yetisir, Bilgin Karaalioglu, Mert Tohumcuoglu
International Journal of Clinical Oncology.2019; 24(2): 168.     CrossRef
Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer
Xiaozhou Yu, Yanjia Zhu, Jian Wang, Xiuyu Song, Lei Zhu, Xiaoyuan Men, Xiaofeng Li, Dong Dai, Wengui Xu
Nuclear Medicine Communications.2017; 38(2): 193.     CrossRef
Prognostic value of pre-treatment 18F-FDG-PET uptake in small-cell lung cancer
Meryem Aktan, Mehmet Koc, Gul Kanyilmaz, Berrin Benli Yavuz
Annals of Nuclear Medicine.2017; 31(6): 462.     CrossRef
The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer
Soo Hyun Kwon, Seung Hyup Hyun, Joon-Kee Yoon, Young-Sil An, Young-Taek Oh, Jin-Hyuck Choi, Kwang Joo Park, Su Jin Lee
Medicine.2016; 95(5): e2772.     CrossRef
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
A. Patnaik, L. J. Appleman, A. W. Tolcher, K. P. Papadopoulos, M. Beeram, D. W. Rasco, G. J. Weiss, J. C. Sachdev, M. Chadha, M. Fulk, S. Ejadi, J. M. Mountz, M. T. Lotze, F. G. S. Toledo, E. Chu, M. Jeffers, C. Peña, C. Xia, S. Reif, I. Genvresse, R. K.
Annals of Oncology.2016; 27(10): 1928.     CrossRef
Deriving global quantitative tumor response parameters from 18F-FDG PET-CT scans in patients with non-Hodgkin’s lymphoma
Frederic Sampedro, Anna Domenech, Sergio Escalera, Ignasi Carrió
Nuclear Medicine Communications.2015; 36(4): 328.     CrossRef
Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer
Si Shi, Shunrong Ji, Yi Qin, Jin Xu, Bo Zhang, Wenyan Xu, Jiang Liu, Jiang Long, Chen Liu, Liang Liu, Quanxing Ni, Xianjun Yu
Cancer Letters.2015; 360(2): 227.     CrossRef
Interpretation and Prognostic Value of Positron Emission Tomography-Computed Tomography After Induction Chemotherapy With or Without Radiation in IIIA-N2 Non-small Cell Lung Cancer Patients Who Receive Curative Surgery
Sung Hwan Kim, Jong Hoon Lee, Guk Jin Lee, Songmi Jeong, Yoo-Kang Kwak, Hoon-Kyo Kim, Deog Gon Cho, Young Ha Park, Mina Yu, Sei Chul Yoon
Medicine.2015; 94(24): e955.     CrossRef